Patent · US Active

Substituted pyrimidines useful as protein kinase inhibitors

US8268829B2 · kind B2 · utility

23Cited by
58References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2009
Grant dateSep 18, 2012
Priority date
Expiry dateApr 16, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D453/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a facile process for the preparation of tri- and tetra-substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora-mediated diseases or conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.